Coloplast


July 25, 2018: Capitol News

July 25, 2018 | Tags: , , , , , , , , , , , , , ,

U.S. House Votes to Repeal Medical Device Tax

Late yesterday afternoon, the U.S. House voted to permanently repeal the Medical Device Excise Tax by a vote of 283-132. The bill – known as The Protect Medical Innovation Act – received strong bipartisan support, including five members of Minnesota’s Congressional delegation. The bill now goes to the U.S. Senate, where a vote could be held later this year.

The medical device industry is a key industry in Minnesota. The state is home to the most densely concentrated medical technology cluster in the world. The overall health technology industry – of which medical devices is a large part – has a $23 billion impact on Minnesota’s economy. The medical device industry alone employs more than 34,000 people in the state. Repealing the medical device tax brings certainty to the healthcare marketplace and prioritizes health-consumer access to the next generation of medical technology solutions.


(Photo: Congressman Paulsen touring Teleflex’s Plymouth facility earlier this year)

We are grateful for the leadership that Congressman Erik Paulsen has provided on this issue. He worked tirelessly with members of both parties to prioritize this issue and repeal this tax. His hard work and dedication are what made this vote possible. We also thank the members of the Minnesota delegation who voted in favor of this legislation: Congressmen Tom Emmer, Jason Lewis, Collin Peterson, and Rick Nolan.

We will be working with Senators Amy Klobuchar and Tina Smith to secure Senate passage of this bill. Senate leadership has not yet indicated when this bill will receive a vote in that chamber. We will continue to keep you updated as more information becomes available.

Medical Alley Association Members Coloplast & Medtronic Host State Legislators

As part of MAA’s mission to connect Minnesota’s healthcare leaders with legislators, two MAA members hosted tours for state legislators in late June. State Representatives Tony Albright, Barb Haley, Nick Zerwas, House HHS Chair Matt Dean, and House staff joined members of the MAA team for tours of Coloplast’s U.S. Headquarters in North Minneapolis and Medtronic’s Electronics and Components Manufacturing Center (MECC) in Brooklyn Park.

At Coloplast, House committee members and staffers met with several members of the Coloplast team including MAA Board Chair Steffen Hovard, who is the President of Urology Care for Coloplast. Legislators and staff heard about the importance of innovation in Minnesota to help attract and retain talent and to keep Minnesota’s market more competitive by funding the Angel Investment Tax Credit.

Thank you Coloplast for a wonderful morning learning about ways you make lives easier for patients.

At MECC, legislators met with employees, toured the facility where components that go into implantable devices like pacemakers, implantable defibrillators, implantable neuro stimulators are designed, built and tested. They were able to see the step by step process that goes into battery systems that are used to power life saving devices.

Thank you Medtronic for bringing us behind the scenes of how their innovations are saving lives and improving quality of life for patients every day.

    

MAA Submits Comment on HHS Proposal for Health Investing & Innovation Workgroup

Earlier this month, MAA submitted a formal public comment in response to HHS’ Request for Information (RFI) regarding ways to better communicate with the Health Innovation and Investing industries. MAA’s comment focused on the structure of the working group and urged HHS to ensure representation from all stages of the life-cycle of innovation and from different parts of the country. Several members of the Minnesota Congressional delegation also submitted a letter to HHS, requesting that Minnesota be “robustly represented” on the workgroup. Thank you to Congressmen Erik Paulsen, Tom Emmer, Collin Peterson, Keith Ellison, Jason Lewis and Congresswoman Betty McCollum for signing the letter.

The deadline for comments was on July 6. HHS has not yet indicated what or when the next steps will be. We will keep you up to date as this progresses.


May 17, 2018: In The Know

May 16, 2018 | Tags: , , , , , , , , , , , , , , ,

Ecolab Ranks Eighth on 2018 Best Corporate Citizens List

Why Medtronic’s CEO Wants to Bring Values-Based Healthcare to Everyone

Boston Scientific’s drug-coated balloon succeeds in femoropopliteal segment at one year

U of M Honored as One the World’s Best at Spinning Off Companies from Research

Coloplast Announces the Launch of Biatain® Silicone with 3DFit Technology™

Blue Cross and Blue Shield of Minnesota Releases 2017 Community Report

Successful Commercialization of Gut Microbe Strain Could Net Mayo $55M

Minnesota med-tech industry seeks China tariff relief

Vyriad to build $9 million facility on former IBM site

Medtronic Begins U.S. Study of Drug-Eluting Stents to Evaluate Treatment of Bifurcation Lesions in Patients with Coronary Artery Disease

Research Brief: UMN researchers make key discovery about human cancer virus protein

Women in Business Awards 2018: Kathleen Skarvan

Q&A With Chris McClain, VP of New Business Development and Sales

Biothera Pharmaceuticals Appoints Andrew D.C. LaFrence Chief Financial Officer

walkasins Tested for Longer-Term Effectiveness in Peripheral Neuropathy

Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis

Aldevron Names Marc Wolff Chief Financial Officer

Sun BioPharma Provides Business Update and Files Report for Q1 2018

Admedus using capital raised to advance product development and share price growth


April 12, 2018: In the Know

April 11, 2018 | Tags: , , , , , , , , , , , , , ,

SecurAcath Selected for Fast-Track NHS Use Through New Innovation and Technology Payment Program

Ferring acquires innovative biotechnology company and microbiome pioneer Rebiotix Inc.

University of Minnesota wins $42 million in federal funds for biomedical research

Medtech start-up Global Kinetics scores first BTF investment, kicks off new trial

CHF

Coloplast Expands its Product Portfolio With New Innovative Ostomy Category

State-funded consortium provides more access statewide to clinical trials for cancer

How CHF Solutions is using health economics to expand product adoption

In Minneapolis, the Spotlight is on “The Silicon Valley of the Midwest”

DiaMedica Therapeutics Announces Appointment of Scott Kellen as Chief Financial Officer

Inspire Medical Systems, Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering

ANI Acquires 23 ANDAs from IDT Australia, Ltd.

Progress MN: MD Biosciences Inc.

Louis T. Ruggiero Named CBO of Collagen Solutions Plc

Magenta Therapeutics Appoints Amy Ronneberg, President of Be The Match BioTherapies, to Board of Directors

Vidscrip, Zipnosis Team Up to Personalize the Virtual Care Experience


February 8, 2018: In the Know

February 8, 2018 | Tags: , , , , , , , , , ,

  1. Boston Scientific meets earnings expectations, sees stronger 2018 sales
  2. GTCR and Regatta Medical Announce Strategic Investment in Resonetics
  3. Biothera Pharmaceuticals Commences Phase II Head and Neck Cancer Study Evaluating Combination of Imprime PGG and Merck’s KEYTRUDA
  4. Coloplast acquires IncoCare Gunhild Vieler GmbH
  5. Player’s Health Headlines Techstars’ Boulder 2018 Class
  6. Caisson Interventional Expanding in Maple Grove
  7. Respicardia names former Boston Scientific exec CEO as first product hits market
  8. Cogentix Medical Announces 17% Preliminary Fourth Quarter 2017 Year-Over-Year Revenue Growth
  9. Bio-Techne Releases Second Quarter Fiscal 2018 Results
  10. New Heraeus Costa Rica facility expected to produce over two million guidewires in 2018 for medical device companies
  11. University Enterprise Laboratories Planning a $6M Building Expansion in St. Paul
  12. Cardiovascular Systems, Inc. Announces Commercial Launch in Japan
  13. NAMSA EXPANDS MEDICAL DEVICE TESTING SERVICES IN GERMANY TO INCREASE ACCESS TO ACCELERATED PRODUCT DEVELOPMENT

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER